Results

Total Results: 1,027 records

Showing results for "drug".

281. Current Processes: Refining Evidence-based Recommendation Development - Table 1 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/current-processes-refining-evidence-based-recommendation-development-table-1
     June 01, 2007 - Food and Drug Administration, Indian Health Service, National Institutes of Health, and Veterans Administration

282. Recommendation: Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions
     November 13, 2018 - Practice Regarding the I Statement Potential Preventable Burden In 2016, the National Survey on Drug … Results from the 2016 National Survey on Drug Use and Health: detailed tables. SAMHSA website. … https://www.samhsa.gov/data/report/results-2016-national-survey-drug-use-and-health-detailed-tables . … Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children … Preventing drug abuse and excessive alcohol use. SurgeonGeneral.gov website.

283. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
     November 01, 2014 - Role of primary care professionals in preventing and reducing drug use in children and adolescents. … Illicit drug use 2. … Interventions that address illegal or prescription drug use in the context of other substances, such … Screening for Illicit Drug Use in Primary Care In the Affordable Care Act, Congress also requested … Drug Use: Interventions for Children and Adolescents The USPSTF concludes that the current evidence

284. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
     November 01, 2014 - Role of primary care professionals in preventing and reducing drug use in children and adolescents. … Illicit drug use 2. … Interventions that address illegal or prescription drug use in the context of other substances, such … Screening for Illicit Drug Use in Primary Care In the Affordable Care Act, Congress also requested … Drug Use: Interventions for Children and Adolescents The USPSTF concludes that the current evidence

285. Screening for Colorectal Cancer: Clinical Summary (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/qSyg242Cz-X9DDwZg6GEhP
     October 07, 2008 - Screening for Colorectal Cancer: Clinical Summary SCREENING FOR COLORECTAL CANCER CLINICAL SUMMARY OF U.S. PREVENTIVE TASK FORCE RECOMMENDATION Population Adults Age 50 to 75* Adults Age 76 to 85 years* Adults Older than 85* Screen with high sensitivity fecal occult blood testing (FOBT), …

286. Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/rQBBkz9CrHh4vp7ZnEkF-t
     July 18, 2023 - Nonstatin-drug trials showed statistically significant lowering of lipid levels in FH populations, but … few studies were available for any single drug. … Harms reported in the short-term drug trials were similar in the intervention and control groups. … combination (simvastatin + ezetimibe) 1 (n = 248) New: 0 Compared with single drug: Total cholesterol … The nonstatin-drug trials show reductions in 1 or more lipid param- eters and are generally associated

287. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4)_0.pdf
     January 01, 2016 - Screening for Intimate Partner Violence, Illicit Drug Use, and Mental Health Conditions 2. … Food and Drug Administration–approved pharmacotherapy for cessation to adults who use tobacco. … Illicit Drug Use Illicit drug use and abuse are serious problems that lead to significant health consequences … Social consequences of illicit drug use include decreased economic productivity, child abuse, family … Food and Drug Administration–approved pharmacotherapy for cessation to adults who use tobacco.

288. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4).pdf
     January 01, 2016 - Screening for Intimate Partner Violence, Illicit Drug Use, and Mental Health Conditions 2. … Food and Drug Administration–approved pharmacotherapy for cessation to adults who use tobacco. … Illicit Drug Use Illicit drug use and abuse are serious problems that lead to significant health consequences … Social consequences of illicit drug use include decreased economic productivity, child abuse, family … Food and Drug Administration–approved pharmacotherapy for cessation to adults who use tobacco.

289. Evidence Summary: Anxiety Disorders in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/anxiety-adults-screening
     June 20, 2023 - In 2020, the US Food and Drug Administration (FDA) issued a warning: …even when taken at recommended … US Food and Drug Administration. Published September 23, 2020. Accessed June 14, 2023. … https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class … US Food and Drug Administration. Published September 20, 2017. Accessed June 14, 2023. … https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class

290. Draft Recommendation: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/latent-tuberculosis-infection-adults
     November 22, 2022 - Food and Drug Administration: T-SPOT.TB (Oxford Immunotec Global), QuantiFERON-TB Gold In-Tube (Qiagen … first medication shown to prevent progression to active TB; however, concerns about hepatotoxicity and drug … 1.08]); post-hoc analyses showed a smaller number of cases of hepatotoxicity attributable to the study drug … increasing risk of progression to active disease (such as diabetes, lupus, cancer, alcoholism, and drug … Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid

291. Screening for Hypertension in Children and Adolescents: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RcckGKJEfBSus5YG89yVpt
     November 10, 2020 - approaches to stop hypertension over 3 months (−2.2 mm Hg, P < .01; n = 57), and by a combination of drug … 4 What is the effectiveness of drug, nondrug, and combination interventions for treating high blood … What is the effectiveness of drug, nondrug, and combination interventions initiated for the treatment … What is the effectiveness of drug, nondrug, and combination interventions initiated for the treatment … What are the adverse effects of drug, nondrug, and combination interventions for treating high blood

292. 8Crjsjsjujfehbpdnupysb (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8cRJsjSJUjfEhBpDNuPysb
     December 01, 2014 - Food and Drug Administration for use on urogenital sites, including male and female urine, as well as … Food and Drug Admin- istration (7). … To maximize adherence, the CDC recommends that drug treatment be dispensed on site. … CDC suggests that clinicians consider expedited partner therapy, which allows for the delivery of a drug … or drug prescription to the partner by the patient, a disease investigation specialist, or a pharmacy

293. Archived: Final Research Plan: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/osteoporosis-screening-june-2018
     November 05, 2015 - Food and Drug Administration for the treatment or prevention of osteoporosis (including bisphosphonates … Food and Drug Administration; biomarkers of bone metabolism, quantitative computed tomography, magnetic

294. Archived: Final Evidence Summary: Depression in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary21/depression-in-children-and-adolescents-screening-2009
     March 15, 2009 - Trials demonstrating the efficacy of drug treatments and time-limited psychotherapies among pediatric … Food and Drug Administration (FDA) has approved for the treatment of pediatric MDD. … antidepressive drug$.ti,ab. selective serotonin reuptake inhibitor$.ti,ab. ssri.ti,ab. … antidepressive drug$.ti,ab. selective serotonin reuptake inhibitor$.ti,ab. ssri.ti,ab. … Adverse drug reaction reporting systems/ Drug toxicity/ Drug hypersensitivity/ Death/ death.ti

295. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
     January 01, 1996 - trial, in which the dose was 500 mg daily, 20% of the doctors taking aspirin had to discontinue the drug … Aspirin is the most consumed drug in the U.S., with an estimated 20-30 billion tablets ingested each … of a first MI are sufficiently high to warrant the possible adverse effects of long-term use of the drug … and cerebrovascular disease, may be more likely to experience hemorrhagic stroke while taking this drug

296. Current Processes: Refining Evidence-based Recommendation Development - Table 2 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/current-processes-refining-evidence-based-recommendation-development-table-2
     June 01, 2007 - Current Processes: Refining Evidence-based Recommendation Development - Table 2 Share to Facebook Share to X Share to WhatsApp Share to Email Print Table 2. Aims and Processes of the USPSTF to Ensure Integrity a Goal Process …

297. Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/eSLqaKpvzhYRbQVeumNgSQ
     January 19, 2021 - 133 64 640 5574 32 918 16.9 3315 31 722 10.5 1.55 (1.49-1.61) 39 NRT, gum Placebo or no drug 56 22 … 13 773 15.7 1131 11 981 9.4 1.64 (1.53-1.75) 24 NRT, inhaler Placebo or no drug 4 976 84 490 17.1 44 … 486 9.1 1.90 (1.36-2.67) 0 NRT, intranasal spray Placebo or no drug 4 887 107 448 23.9 52 439 11.8 … ) 71 NRT, participant's choice Placebo or no drug 7 8288 793 4179 19.0 569 4109 13.8 1.37 (1.25-1.52 … Pharmacoepidemiol Drug Saf. 2020;29(1):94-102. doi:10.1002/pds.4894 114.

298. Evidence Summary: Nonpregnant Adolescents and Adults: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nonpregnant-adolescents-and-adults1/human-immunodeficiency-virus-hiv-infection-screening
     June 11, 2019 - Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B … in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug

299. Screening for Cognitive Impairment in Older Adults (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/nnH5ErSpve7SEgGjbquev4
     March 01, 2014 - The Task Force looked at the benefits and harms of drug treatments for cognitive impairment.

300. Interventions for Tobacco Smoking Cessation in Adults (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/rUDuAkaruoWe--aVrzfGQN
     June 29, 2020 - to help people quit include behavioral counseling and, for adults who are not pregnant, Food and Drug … Food and Drug Administration (FDA)-approved pharmacotherapy for cessation to adults who use tobacco